Roche Holding AG (OTCQX International Premier:RHHBF)
| 347.00 Delayed Data As of Feb 02 |  +3.93 / +1.15%Today’s Change | 333.69 Today|||52-Week Range 466.14 | -10.91% Year-to-Date |
Latest RHHBF News | Press Releases
| Regeneron (REGN) Q4 Earnings & Sales Beat, Eylea Sales Decline 11:35am / Zacks.com - Paid Partner Content | Will Keytruda & Gardasil Aid Merck (MRK) Sales in Q4 Earnings? Feb 01 / Zacks.com - Paid Partner Content |
| Sanofi (SNY) Q4 Earnings Miss Estimates, Vaccine Sales Weak 9:55am / Zacks.com - Paid Partner Content | J&J (JNJ) Q4 Earnings Beat, Sales Miss, 2023 EPS View Upbeat Jan 24 / Zacks.com - Paid Partner Content |
| Roche's (RHHBY) 2022 Core Earnings Grow, 2023 Outlook Dismal Feb 02 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 343.07 |
| Today’s open | 333.69 |
| Day’s range | 333.69 - 353.50 |
| Volume | 180 |
| Average volume (3 months) | 66 |
| Market cap | $39.1B |
Data as of 02/02/2023
Growth & Valuation
| Earnings growth (last year) | +0.63% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +10.55% |
| P/E ratio | -- |
| Price/Sales | 5.62 |
| Price/Book | 10.91 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $68.7B |
| Annual profit (last year) | $15.2B |
| Net profit margin | 22.18% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basel, Basel-stadt (basle Town) |
Forecasts
Chart unavailable
